学術雑誌論文 Concomitant T790M mutation and small-cell lung cancer transformation after acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor

Fujita, Kohei  ,  Kim, Young Hak  ,  Yoshizawa, Akihiko  ,  Mio, Tadashi  ,  Mishima, Michiaki

5 ( 1 ) 2017-01-01 , Wiley-Blackwell Publishing Ltd
ISSN:2051-3380
内容記述
A 70-year-old man was admitted to our hospital with an abnormal chest X-ray shadow. Bronchoscopy revealed an adenocarcinoma tumour with an epidermal growth factor receptor (EGFR) exon 19 deletion. Positron emission tomography-computed tomography scanning and magnetic resonance imaging showed advanced stage IV lung cancer. He was treated with erlotinib as a first-line drug, which maintained a clinical response for 16 months. After disease progression, a re-biopsy was done from the tumour in the right lower lobe. The obtained specimen harboured both small-cell lung cancer (SCLC) transformation with retention of the EGFR 19 deletion and the development of an EGFR T790M mutation. We came across a very rare condition of concomitant T790M mutation and SCLC transformation after acquired resistance to EGFR-tyrosine kinase inhibitor.
本文を読む

http://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/218320/1/rcr2.206.pdf

このアイテムのアクセス数:  回

その他の情報